financetom
Business
financetom
/
Business
/
Market Chatter: Starboard Value Acquires Stake in Starbucks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Starboard Value Acquires Stake in Starbucks
Aug 12, 2024 2:54 AM

05:36 AM EDT, 08/12/2024 (MT Newswires) -- Activist investor Starboard Value has taken a stake in Starbucks ( SBUX ) and is pushing the coffee retailer to take measures to increase its stock price, The Wall Street Journal reported late Friday, citing people familiar with the matter.

The report said Starboard's specific demands and stake size are unclear.

The move comes amid Starbucks' ( SBUX ) ongoing negotiations with another activist, Elliott Investment Management, which also has a stake and is advocating for changes, according to the Journal.

The report said that if Elliott fails to secure board representation, it might pursue a proxy battle for seats, and it isn't clear whether Starboard will also look for board seats.

Starboard Value and Starbucks ( SBUX ) did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 77.59, Change: +2.50, Percent Change: +3.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
May 24, 2024
May 24 (Reuters) - Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to detailed results from a late-stage trial presented on Friday. The company in March reported that the diabetes drug known chemically as semaglutide cut the combined risk of...
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
May 24, 2024
06:30 AM EDT, 05/24/2024 (MT Newswires) -- Workday (WDAY) shares tanked early Friday as the cloud human resources company lowered its full-year subscription sales outlook amid slowing headcount growth, despite recording better-than-expected fiscal first-quarter results. Subscription revenue is now set to come in between $7.7 billion and $7.73 billion for fiscal 2025, representing annual gains of about 17%, the company...
Fairfax Asia Chairman/CEO Athappan Passes Away
Fairfax Asia Chairman/CEO Athappan Passes Away
May 24, 2024
06:31 AM EDT, 05/24/2024 (MT Newswires) -- Fairfax Financial ( FRFHF ) overnight Thursday said Fairfax Asia Chairman and CEO Ramaswamy Athappan has passed away. The company didn't mention the cause of death or Athappan's age. He played a major role in developing Fairfax's insurance operations in Southeast Asia, the company said. Mr. Athappan was an exceptional leader with an...
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
May 24, 2024
06:20 AM EDT, 05/24/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Workday (WDAY) shares were down 12% in premarket activity on Friday after the company cut its fiscal 2025 subscription-revenue guidance, taking the shine out of its Q1 earnings and revenue beat. The company reported fiscal Q1 non-GAAP net income late Thursday...
Copyright 2023-2026 - www.financetom.com All Rights Reserved